首页|中性粒细胞/淋巴细胞比值联合肿瘤标志物对结直肠癌的诊断价值

中性粒细胞/淋巴细胞比值联合肿瘤标志物对结直肠癌的诊断价值

扫码查看
目的 探讨中性粒细胞/淋巴细胞比值(NLR)联合肿瘤标志物癌胚抗原(CEA)、糖类抗原19-9(CA19-9)对结直肠癌(CRC)的诊断价值.方法 回顾性分析205例CRC患者(CRC组)和347例结直肠良性息肉患者(对照组)的临床资料.比较两组患者手术前或肠镜检查前血清CEA、CA19-9和NLR的差异.绘制ROC曲线分析CEA、CA19-9和NLR单独或联合检测对CRC的诊断价值.结果 CRC组CEA、CA19-9和NLR高于对照组(P<0.01).CEA、CA19-9和NLR均与CRC患者肿瘤浸润深度、淋巴结转移、远处转移及脉管浸润情况相关(P<0.05).ROC曲线分析显示,CEA、CA19-9与NLR联合检测诊断CRC的AUC、灵敏度和特异度高于CEA、NLR、CA19-9单独检测及CEA与CA19-9联合检测(P<0.05).结论 CRC患者CEA、CA19-9和NLR增高,三者联合检测可提高对CRC的诊断效能.
The value of neutrophil/lymphocyte ratio combined with tumor markers in the diagnosis of colorectal cancer
Objective To investigate the diagnostic value of neutrophil/lymphocyte ratio(NLR)combined with tumor markers carcinoembryonic antigen(CEA)and carbohydrate antigen 19-9(CA19-9)in colorectal cancer(CRC).Methods The clinical data of 205 CRC patients(CRC group)and 347 colorectal benign polyps patients(control group)were retrospectively analyzed.The differences of CEA,CA19-9 and NLR before operation or colonoscopy were compared between the two groups.ROC curve was drawn to analyze the diagnostic value of CEA,CA19-9 and NLR alone or in combination for CRC.Results The levels of CEA,CA1 9-9 and NLR in CRC group were higher than those in control group(P<0.01).The levels of CEA,CA19-9 and NLR were correlated with tumor invasion,lymph-node metastasis,distant metastasis and vascular invasion in CRC patients(P<0.05).ROC curve analysis showed that the AUC,sensitivity and specificity of CEA,CA19-9 and NLR combined detection in the diagnosis of CRC were higher than those of CEA,NLR or CA19-9 detected alone and the combined detection of CEA and CA19-9(P<0.05).Conclusion CEA,CA19-9 and NLR are increased in CRC patients,and the combined detection of the three indexes can improve the diagnostic efficiency of CRC.

Colorectal cancerCarcinoembryonic antigenCarbohydrate antigen 19-9Neutrophil/lymphocyte ratio

张欢、林梵

展开 >

510010 广东广州,中国人民解放军南部战区总医院放射治疗科

510010 广东广州,中国人民解放军南部战区总医院消化内科

结直肠癌 癌胚抗原 糖类抗原19-9 中性粒细胞/淋巴细胞比值

广州市科技计划项目

201704020157

2024

江苏医药
江苏省人民医院(南京医科大学第一附属医院)

江苏医药

影响因子:0.707
ISSN:0253-3685
年,卷(期):2024.50(1)
  • 1